🇺🇸 Hyperbaric Bupivicaine in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Drug Ineffective — 1 report (100%)
Other Anesthesia approved in United States
Frequently asked questions
Is Hyperbaric Bupivicaine approved in United States?
Hyperbaric Bupivicaine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Hyperbaric Bupivicaine in United States?
University of Witwatersrand, South Africa is the originator. The local marketing authorisation holder may differ — check the official source linked above.